PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 27 results · Off-label Promotion · Respiratory  · Clear
🔒 Subscribers only
AUTH/3922/6/24
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Complainant v GSK
An anonymous health professional complained about a 5-frame rotating banner advert on GSK’s UK HCP promotional site (GSKPro) for Trelegy Ellipta.The banner used an image of a COPD patient (“Joh…
Clauses: NONE
2024 🔒 Subscribe
🔒 Subscribers only
AUTH/3771/6/23
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Complainant v GSK
An anonymous, contactable complainant (described as a health professional; later became non-contactable) complained about a GSK Pro promotional webpage for Trelegy Ellipta.The page included a NICE …
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3849/11/23
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca breach for funding declaration not prominent from the outset (AUTH/3849/11/23)
An anonymous, non-contactable complainant alleged a severe asthma article in a named publication was funded by AstraZeneca but did not disclose this at the outset; the funding was only mentioned at…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3709/11/22
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca breach over
A health professional complained about a Trixeo (formoterol fumarate dihydrate/glycopyrronium/budesonide) print advertisement in the October 2022 edition of Pulse magazine (aimed at GPs).The ad hea…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3699/10/22
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca v GSK
AstraZeneca complained about GSK’s UK HCP promotional webpage and embedded video on the Trelegy (FF/UMEC/VI) GSKpro site, which presented results from a published Network Meta-analysis (NMA) in C…
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3664/6/22
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca
An anonymous, contactable health professional complained about a promotional email for Symbicort Turbohaler (budesonide, formoterol fumarate).The email subject line was: ‘AstraZeneca promotional …
Clauses: NONE
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3678/8/22
Off-label Promotion Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca breached Code over Symbicort MART messaging and missing PI reference in
An anonymous, contactable health professional complained about a Symbicort (budesonide/formoterol) hard-copy advertisement in the June 2022 edition of MIMS (ref GB-35766, April 2022), appearing on …
Clauses: 4.1,4.3
2022 🔒 Subscribe
🔒 Subscribers only
AUTH/3257/10/19
Off-label Promotion Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK
GlaxoSmithKline (GSK) voluntarily admitted that a sponsored promotional email for Trelegy Ellipta (ref PM-GB-FVU-EML-190028) sent on 16 September 2019 contained prescribing information dated Novemb…
Clauses: 4.1,4.3
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3175/3/19
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK misleadingly implied NICE endorsement for Anoro Ellipta and blurred licensed indication context
An anonymous health professional complained about a two-page Anoro Ellipta advertisement (ref UK/UCV/0028/18) in the February 2019 edition of Guidelines in Practice.Each page featured a prominent b…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3058/8/18
Off-label Promotion Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Proveca letter on unlicensed/off-label
Two prescribing team pharmacists from a CCG (AUTH/3058/8/18) and a community pharmacist (AUTH/3060/8/18) complained about a Proveca letter (ref Sia/Legal/01) sent in August 2018 about supply/dispen…
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3039/5/18
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Dr Falk
Tillotts complained about a Dr Falk Pharma UK Ltd advertisement for Budenofalk (budesonide) (ref DrF17/159).Budenofalk existed as multiple products sharing the root name: 3mg gastro-resistant capsu…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2945/3/17
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous community pharmacist complained about an NPA booklet, Managing COPD in the community, Resources for pharmacists (Ref UK/RET/0007/16), which carried both NPA and GlaxoSmithKline (GSK) l…
Clauses: NONE
2017 🔒 Subscribe
🔒 Subscribers only
AUTH/2843/4/16
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Boehringer Ingelheim breached Code over
An anonymous, non-contactable complainant challenged promotion of COPD inhalers, highlighting concerns about off-label-style messaging around exacerbation reduction.The complaint focused on a Spiri…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2841/4/16
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK case AUTH/2841/4/16
An anonymous complainant alleged off-label promotion of LABA/LAMA inhalers for COPD exacerbation reduction, focusing on GSK’s Anoro Ellipta (vilanterol/umeclidinium). The complainant highlighted …
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2840/4/16
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Novartis & Pfizer
An anonymous, non-contactable complainant alleged that COPD inhalers licensed to relieve symptoms were being promoted as if indicated to reduce exacerbations.Products: Ultibro Breezhaler (indacater…
Clauses: NONE
2016 🔒 Subscribe
🔒 Subscribers only
AUTH/2810/12/15
Off-label Promotion Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Teva breached ABPI Code over ‘intuitive’ inhaler ad for DuoResp Spiromax (AUTH/2810/12/15)
An anonymous, non-contactable complainant (self-described GP) challenged a Teva UK advertisement for DuoResp Spiromax placed in Primary Care Respiratory Update.The ad featured a patient image with …
Clauses: 3.1,3.2
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2750/3/15
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
Actelion complained about two GlaxoSmithKline UK leavepieces for Volibris (ambrisentan) used with clinicians in UK adult PAH reference centres.Leavepiece A (ref UK/ABT/0023/14) was a 4-page chart t…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2734/9/14
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Boehringer Ingelheim
A prescribing support pharmacist complained about a Striverdi (olodaterol) Respimat leavepiece (ref UK/SVR – 141004(1)) issued by Boehringer Ingelheim.The front cover showed an older woman, smili…
Clauses: NONE
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2710/4/14
Off-label Promotion Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GP complaint upheld
A general practitioner complained about a Meda Pharmaceuticals Ltd advertisement for Dymista (fluticasone/azelastine nasal spray) published in GP on 28 April 2014.The ad prominently stated Dymista …
Clauses: 4.1,4.3
2014 🔒 Subscribe
🔒 Subscribers only
AUTH/2430/8/11
Off-label Promotion Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Johnson & Johnson misleading Nicorette QuickMist mailing (60-second craving relief and cost per day)
GlaxoSmithKline Consumer Healthcare complained about a prescriber mailing (ref 06458) for Nicorette QuickMist (nicotine mouthspray) distributed by Johnson & Johnson Limited.The mailing prominen…
Clauses: 3.2,9.1
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2362/10/10
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Novartis
Boehringer Ingelheim complained about a six-page, gate-folded leavepiece (ref IND10-010) for Onbrez Breezhaler (indacterol inhalation powder) issued by Novartis.Onbrez was promoted for maintenance …
Clauses: NONE
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2081/1/08
Off-label Promotion Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Teva
A pharmacist at a Primary Care Trust (PCT) complained about a supplement sent with the electronic edition of Guidelines in Practice, titled “Making an informed choice A guide to changing to CFC-f…
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2185/11/08
Off-label Promotion Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Schering-Plough
A pharmacist practitioner complained about a NeoClarityn (desloratadine) advertisement placed in GP (7 November) by Schering-Plough.The ad headline was “Triple stopping power for allergic rhiniti…
Clauses: 3.2,4.1
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2060/10/07
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Teva UK Ltd — Qvar; Clenil Modulite
A general practitioner complained about an insert distributed with the September 2007 issue of Guidelines in Practice, titled “Making an informed choice. A guide to changing to CFC-free beclometa…
Clauses: 7.2,7.4,9.5,18.4
2007 🔒 Subscribe
1 2 Next → Page 1 of 2 — 27 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews